Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease
- PMID: 32113572
- DOI: 10.1016/S2213-2600(20)30012-6
Challenges in evidence-based therapy for systemic sclerosis associated interstitial lung disease
Comment on
-
Systemic sclerosis-associated interstitial lung disease.Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27. Lancet Respir Med. 2020. PMID: 32113575 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical